搜索医生

Qun Lu, M.D.

  1. Pathologist
预约门诊

出版物

  1. DelBaugh RM, Murphy MF, Staves J, Fachini RM, Wendel S, Hands K, Bonet-Bub C, Kutner JM, Cohn CS, Cox CA, Jacquot C, Hasan RA, Lu W, Juskewitch JE, Raval JS, Rollins-Raval MA, Fung MK, Ziman A, Fermon EJ, Gorlin JB, Peters J, Dunbar NM, BEST foRmation of Anti-D After Rhogam (RADAR) Study Investigators and the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Why do people still make anti-D over 50 years after the introduction of Rho(D) immune globulin? A Biomedical Excellence for Safer Transfusion (BEST) Collaborative study. Transfusion. 2025 Mar 10 [Epub ahead of print]
    View PubMed
  2. Williams LA 3rd, Adamski J, Kinard TN, Ertz-Archambault NM, Lu Q, Gray K, Herrick JL, Su L, Padrnos L. The first reported use of red blood cell exchange to treat hemoglobin Evans with secondary methemoglobinemia. J Clin Apher. 2023 Dec; 38 (6):755-759 Epub 2023 Sept 04
    View PubMed
  3. Williams LA 3rd, Thiele BA, Kinard T, Kaleta E, Adamski J, Su L, Jones S, Lu Q. Thawed plasma (TP) as a substitute for intravenous immune globulin (IVIG) to prevent hypogammaglobulinemia post-therapeutic plasma exchange. Transfus Apher Sci. 2023 Aug; 62 (4):103716 Epub 2023 May 02
    View PubMed
  4. Pokorney SD, Piccini JP, Stevens SR, Patel MR, Pieper KS, Halperin JL, Breithardt G, Singer DE, Hankey GJ, Hacke W, Becker RC, Berkowitz SD, Nessel CC, Mahaffey KW, Fox KA, Califf RM, ROCKET AF Steering Committee & Investigators//ROCKET AF Steering Committee Investigators. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF. J Am Heart Assoc. 2016 Mar 8; 5 (3):e002197 Epub 2016 Mar 08
    View PubMed
  5. Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation. 2014 Jul 8; 130 (2):138-46 Epub 2014 June 03
    View PubMed
  6. Lin DM, Goldfinger D, Lu Q, Wallace B, Kosak-Nguyen D, Wood A, Porter B, Bumerts P, Jeffery R, Fang A, Stalcup I, Penaflorida T, Ziman A. Measuring trade-offs that matter: assessing the impact of a new electronic cross-match policy on the turnaround time and the cross-match workload efficiency. Transfusion.2014;54:3075-9.
  7. Dumani D, Peterson JM, Lu Q, Ziman A. The role of exchange transfusion in neonatal hemochromatosis: A case report of this rare entity and a literature review (accepted). Check Sample of American Society of Clinical Pathology. 2014.
  8. Cheng S, Wu Y, Lu Q, Yan J, Zhang H, Wang X. Autophagy genes coordinate with the class II PI/PtdIns 3-kinase PIKI-1 to regulate apoptotic cell clearance in C. elegans. Autophagy. 2013 Dec; 9 (12):2022-32 Epub 2013 Oct 21
    View PubMed
  9. Peterson J, Yuan S, Lu Q. Dendritic cell vaccination for treatment of a variety of cancers. ASCP Case Reports. 2013; 56(2).
  10. Schwartz GG, Olsson AG, Abt M, Ballantyne CM, Barter PJ, Brumm J, Chaitman BR, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Mundl H, Nicholls SJ, Shah PK, Tardif JC, Wright RS. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med. 2012 Nov 29; 367 (22):2089-99 Epub 2012 Nov 05
    View PubMed
  11. Kaur JS, Coe K, Rowland J, Braun KL, Conde FA, Burhansstipanov L, Heiney S, Kagawa-Singer M, Lu Q, Witte C. Enhancing life after cancer in diverse communities. Cancer. 2012 Nov 1; 118 (21):5366-73 Epub 2012 Mar 20
    View PubMed
  12. Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012 Apr; 11 (4):315-22 Epub 2012 Mar 07
    View PubMed
  13. Damani D, Ziman A, Lu Q. Granulocyte Transfusion. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2012; 55(8).
  14. Yuan S, Hoffman M, Lu Q, Goldfinger D, Ziman A. Motivating factors and deterrents for blood donation among donors at a university campus-based collection center. Transfusion. 2011 Nov; 51: (11)2438-44.
    View PubMed
  15. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8; 365 (10):883-91 Epub 2011 Aug 10
    View PubMed
  16. Finck RH, Davis RJ, Teng S, Goldfinger D, Ziman AF, Lu Q, Yuan S. Performance of an automated solid-phase red cell adherence system compared with that of a manual gel microcolumn assay for the identification of antibodies eluted from red blood cells. Immunohematology. 2011; 27: (1)1-5.
    View PubMed
  17. Nagao B, Yuan S, Lu Q. Drug-induced hemolytic anemia and Thrombocytopenia. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2011; 54(4):41-52.
  18. Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger D. Moderate and severe adverse events associated with apheresis donations: incidences and risk factors. Transfusion. 2010 Feb; 50: (2)478-86.
    View PubMed
  19. Yuan S, Ziman A, Smeltzer B, Lu Q, Goldfinger D. Moderate and severe adverse events associated with blood component donations by apheresis: incidence and risk factors. Transfusion. 2010; 50:478-86.
  20. Smith D, Lu Q, Yuan S, Goldfinger D, Fernando LP, Ziman A. Survey of current practice for prevention of transfusion-transmitted cytomegalovirus in the United States: leucoreduction vs. cytomegalovirus-seronegative. Vox Sang. 2010 Jan; 98: (1)29-36.
    View PubMed
  21. Shackley BS, Pullarket ST, Tanaka-Mukai D, Lu Q. Chagas Disease: a growing concern in the United States. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2010; 53(5):51-61.
  22. Sohsman M, Yuan S, Ziman A, Lu Q. Dramatic increase of antibody titers and severe hemolytic disease of the fetus and newborn following an episode of mild vaginal bleeding. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2010; 53(4):39-49.
  23. Schwartz GG, Olsson AG, Ballantyne CM, Barter PJ, Holme IM, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Shah PK, Tardif JC, Chaitman BR, Duttlinger-Maddux R, Mathieson J, dal-OUTCOMES Committees and Investigators. Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome. Am Heart J. 2009 Dec; 158 (6):896-901.e3
    View PubMed
  24. Yuan S, Ziman A, Anthony MA, Tsukahara E, Hopkins C, Lu Q, Goldfinger D. How do we provide blood products to trauma patients? Transfusion. 2009 Jun; 49: (6)1045-9.
    View PubMed
  25. Arndt P, Garratty G, Isaak E, Bolger M, Lu Q. Positive direct and indirect antiglobulin tests associated with oxaliplatin can be due to drug antibody andor drug-induced nonimmunologic protein adsorption. Transfusion. 2009 Apr; 49: (4)711-8.
    View PubMed
  26. Booth G, Ogbu A, Lu Q, Ziman A. Paroxysmal cold hemoglobinuria. Check Sample of American Society of Clinical Pathology, Transfusion Medicine. 2009.
  27. Heddle NM, Cook RJ, Tinmouth A, Kouroukis CT, Hervig T, Klapper E, Bandwein JM, Szczepiorkowski ZM, AuBuchon JP, Barty RL, Lee, KA, STOP Investigators. A randomized controlled trial comparing standard and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia. Blood. 2008 Dec; 113(7):1564-73.
  28. Hopkins CK, Yuan S, Lu Q, Ziman A, Goldfinger D. A severe case of atypical hemolytic uremic syndrome associated with pneumococcal infection and T activation treated successfully with plasma exchange. Transfusion. 2008 Nov; 48: (11)2448-52.
    View PubMed
  29. Hopkins C, Yuan S, Lu Q, Ziman A, Goldfinger D. A severe case of atypical HUS associated with pneumococcal infection and T-activation treated successfully with plasmapheresis. Transfusion. 2008 Jul; 48(11):2448-52.
  30. Yuan S, Goberger J, Smeltz B, Ziman A, Lu Q, Goldfinger D. Risk factors associated with multicomponent apheresis collection of blood products. Transfusion. 2008 Jun; 48(6):1213-9.
  31. Yuan S, Gornbein J, Smeltzer B, Ziman AF, Lu Q, Goldfinger D. Risk factors for acute, moderate to severe donor reactions associated with multicomponent apheresis collections. Transfusion. 2008 Jun; 48: (6)1213-9.
    View PubMed
  32. Lu Q, Nedelcu E, Ziman A, Bumerts P, Fernando L, Schiller G. Standardized protocol to identify high-risk patients undergoing therapeutic apheresis procedures. J Clin Apher. 2008; 23: (3)111-5.
    View PubMed
  33. Hooper J, Lu Q, Pepkowitz S. Disseminated coccidioidomycosis in pregnancy. Archives of Pathology and Laboratory Medicine. 2007; 131:652-5.
  34. Lu Q, Goldfinger D. Managing patients with warm autoimmune hemolytic anemia. Check Sample of American Society of Clinical Pathology. 2007; 507(7):81-93.
  35. Tang Y-R, Lu Q, Su P-M, Zhou Z-F. The use of metronidazole in postpartum infections in patients with hepatitis. Jiangusu Pharmaceutical and Clinical Research. 1996; 4(3):37-8.
  36. Su P-M, Zhou Z-F, Tang Y-R, Wang E-F, Guo C-Y, Zhao B, Lu Q, Tang X. Placental volume in patients with hepatitis during their pregnancy. Jiangsu medicine. 1990; 5:12-5.
  37. Zhou Z-F, Sun X-B, Lu Q, et al. Causes of high serum SGPT in pregnancy. Jiangsu Medicine. 1989; 15(9):506.
PST-20217311